Silver Silver
order now Order Ahead
Published
September 18, 2020

Five States May Legalize Cannabis This November

In 2016, the US election resulted in a green wave as cannabis legalization measures passed in eight out of nine states.

Now, the industry and its supporters are hoping for another big win in November.

This year, voters in five states will decide whether to adopt either new medical or recreational cannabis laws -- or, perhaps, both in the case of one state.

As it stands now, 33 states have legalized medical cannabis, and of those, 11 states have legalized cannabis for adult recreational use.

Cannabis sales in states that have legalized the plant for medical and recreational purposes totaled about $15 billion in 2019, and are expected to top $30 billion by 2024, according to data from BDS Analytics, which tracks dispensary sales.

Below is a look at the five states voting on legal cannabis this November.

Arizona

Four years ago, residents in the Grand Canyon State narrowly defeated an initiative to legalize recreational cannabis. It failed by fewer than 67,100 votes, with 51.3% of voters saying no.

For the most part, Proposition 207 is structured similarly to 2016's measure. It would allow adults 21 years and older to possess, consume or transfer up to 1 ounce of cannabis and create a regulatory system for the products' cultivation and sale. Some key differences with the new measure include the addition of social equity provisions and criminal justice reforms such as record expungement.

According to estimates from industry publication Marijuana Business Daily, recreational sales in Arizona could total $700 million to $760 million by 2024.

New Jersey

When Governor Phil Murphy was elected in 2017, he vowed to deliver on a campaign trail promise to legalize cannabis.

However, legislative efforts to legalize failed to drum up enough support. Lawmakers ultimately decided to go another route and put the measure before voters.

If approved, Public Question No. 1 would legalize cannabis for adults 21 and older. The program will be regulated by the same commission that oversees New Jersey's medical cannabis businesses, and the recreational cannabis products would be subject to the state sales tax (currently 6.625%).

South Dakota

Usually states have legal medical cannabis programs in place before adopting recreational cannabis laws. South Dakota could enact medical and recreational programs in one fell swoop.

Voters in South Dakota will decide on Measure 26, which would establish a medical cannabis program and registration system for people with qualifying conditions, as well as on Amendment A, which would legalize cannabis for all adults and require state legislators to adopt medical cannabis and hemp laws.

Montana

Montana voters also will see two cannabis initiatives on their ballots.
Ballot issue I-190 would allow adults in the state to possess, buy and use cannabis for recreational use. A separate initiative, CI-118, would establish 21 as the legal age to purchase, possess and consume cannabis.

If passed, I-190 would establish a 20% tax on recreational cannabis, with more than half of the tax collections landing in the state general fund and the rest allocated to programs such as enforcement, substance abuse treatment and veterans' services. The measure also would allow people serving a sentence for certain cannabis-related acts to apply for resentencing or records expungement.

Mississippi

In Mississippi, there are two competing measures to legalize cannabis for medical purposes.
Initiative 65, which resulted from a citizen petition, would allow physicians to recommend medical cannabis for patients with any of 22 qualifying conditions such as cancer, multiple sclerosis and post-traumatic stress disorder. The constitutional amendment would establish a regulatory program for businesses to grow and sell medical cannabis and for the products to be taxed at a 7% rate.

Under Mississippi law, the legislature has the option to amend or draft an alternate measure, and that's what it did here via Initiative 65A. The competing measure requires medical products that are of pharmaceutical quality, limits the smoking of medical cannabis to people who are terminally ill, and leaves the future creation of rules and a regulatory framework up to the legislature.

Based on the article published on CNN.com
You Might Also Like
Specials
Infused Non-Flower Deal
Infused Non-Flower Deal

Exclusive deal on all non-flower products.

View Details View Details
Student discount
Student Discount

A discount on all your favorite products.

View Details View Details
Celebration Sunday
Celebration Sunday

Don't miss out on premium flower at discount prices.

View Details View Details
Shatterday
Shatterday

Save big on the products you love!

View Details View Details
Fabulous Friday
Fabulous Friday

Get discounted ounces, flower and joints

View Details View Details
Therapeutic Thursday
Therapeutic Thursday

Save big on the products you love!

View Details View Details
Tasty Tuesday
Tasty Tuesday

Your favorite edibles at a special price.

View Details View Details
Medical Half Ounce Special
Medical Half Ounce Special

Stock up on premium strains at a great price

View Details View Details
Close